AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUN 11 - (NewsRx.com & NewsRx.net) -- Group B Streptococcus vaccines to prevent infection by capsulate bacteria causing pneumonia are currently being developed.
According to recent research published in the journal Current Opinion in Pulmonary Medicine, "Pneumonia strikes the extremes of the age spectrum, causing maximal death and disability in children and the elderly. Despite its worldwide impact, there is a paucity of epidemiologic data regarding its incidence and the causative organisms."
"The two leading causes of bacterial pneumonia in childhood are Streptococcus pneumoniae (SP) and Haemophilus influenzae type b (Hib)," reported Fiona Mary Russell and Jim Buttery at the University of Melbourne in Australia. "SP is the major cause of pneumonia beyond the newborn period. In neonates, Group B Streptococcus (GBS) remains a major cause of sepsis and pneumonia despite recent reductions due to targeted perinatal antibiotic prophylaxis."
"Hib vaccine can prevent pneumonia in developing countries," said Russell and Buttery. "SP conjugate vaccine prevents X-ray confirmed pneumonia in low incident populations, but ...
Source: HighBeam Research, Group B Streptococcus vaccines under development.